[Today's focus]

Samsonite (01910.HK) annual profit attributable to shareholders of $417 million increased 33.3% year over year

Samsonite (01910.HK) announced that for the year ended December 31, 2023, the company's net sales were US$3,682.4 million, an increase of 27.9% over the previous year (30.0% increase on a constant exchange rate basis). After excluding net sales in Russia, consolidated net sales for the year ended 31 December 2023 increased by USD 812.5 million, or 28.3% (30.4% on a constant exchange rate basis) compared to the year ended 31 December 2022.

The gross margin for the year ended December 31, 2023 was 59.3%, compared to 55.8% for the year ended December 31, 2022. The increase in gross margin is mainly due to the year-on-year improvement in gross margin in all regions, while the share of total net sales in Asia, which has the highest gross margin, has increased. The increase in gross margin was also due to an increase in the share of Tumi brands with high profit margins in total net sales, an increase in the share of net sales directly to consumers in total net sales, and an overall reduction in promotional discounts.

Profit attributable to equity holders for the year ended December 31, 2023 was $417.0 million, an improvement of $104.3 million, or 33.3%, from $312.7 million last year. Adjusted EBITDA is a non-IFRS measurement tool, improving from $472.3 million, or 50.2%, for the year ended 31 December 2022 to $709.3 million for the year ended 31 December 2023.

[Important matters]

China Tianhua Chemical (00362.HK) plans to establish a joint venture to produce and sell mineral products and chemical products

[Financial results]

Samsonite (01910.HK) annual profit attributable to shareholders of $417 million increased 33.3% year over year

Profit attributable to owners of Yuyuan Group (00551.HK) of US$275 million decreased by 7.3% year-on-year

Baosheng International (03813.HK): Achieving net profit of 490 million yuan in 2023, a year-on-year increase of 450.0%

Vietnam's manufacturing, processing and export (00422.HK) annual revenue of US$105 million decreased by 20.9% year-on-year

PricewaterhouseCoopers (01358.HK) Yingxi: Net profit is expected to increase 33% to 55% in 2023

Territory Holdings (06999.HK) Profit Alert: Expected annual net loss of about 800 million to 1.1 billion yuan

Wancheng Holdings (02892.HK) expects a loss of $530 million to 680 million yuan in fiscal year 2023

FUTURE BRIGHT (00703.HK) Yingxi: Expected annual profit attributable to company owners is approximately HK$48.8 million

Tianjin Development (00882.HK) Yingxi: Net profit is expected to increase by about 70% to 80% year-on-year in 2023

Bestar Holdings (01168.HK) Profit Alert: Company owners are expected to account for a loss of not less than HK$250 million in 2023

Little Yellow Duck (02250.HK) Profit Alert: Expected loss of over HK$40 million in 2023

Orange Sky Jiahe (01132.HK) Profit Alert: Expected net loss of not less than HK$90 million in 2023

Fengdeli Holdings (00571.HK): Comprehensive loss attributable to company owners is expected to increase by no less than 25% in the medium term

[Operational data]

China Metallurgical (01618.HK): The amount of new contracts signed in January-February was 195.41 billion yuan, up 0.4% year-on-year

Zhongan Online (06060.HK)'s total insurance premium income from January to February was about 4,543 billion yuan

CGN New Energy (01811.HK): Completed 1452.5 gigawatt-hours of power generation in February, an increase of 10.4% year-on-year

The total power generation capacity of Shantao New Energy (01250.HK) in 2023 was about 5.644 million megawatt-hours, up about 14.5% year-on-year

[Pharmaceutical Innovation]

Jiahe Bio-B (06998.HK): China National Drug Administration accepted the marketing license application for a new drug of lerocilide hydrochloride tablets (GB491, Lerociclib)

China Biopharmaceutical (01177.HK): Phase II clinical study data for the KRAS G12C inhibitor “GARSORASIB (D-1553 tablets)” will be announced at 2024 AACR

[Acquisition and sale]

China Glass (03300.HK) spent 507.33 million yuan to compete for land use rights in Horqin Zuoyi Houqi Industrial Park in Tongliao City, Inner Mongolia

NIRAKU (01245.HK) plans to acquire land in Fukushima Prefecture, Japan for approximately HK$14.7 million

[Equity Incentives]

Standard Chartered Group (02888.HK) awarded a total of 2,315,000 share awards

Kingsley Biotech (01548.HK) grants 444,600 restricted shares

BeiGene (06160.HK): A total of 78,600 American Depositary Shares were purchased by 3,410 participants in accordance with employee stock purchase plans

[Issuance of additional shares]

Xinneng Low Carbon (00145.HK) shares were subscribed for approximately 21.78%

China Tianhua Chemical (00362.HK) plans to discount about 13.79% by issuing 108 million shares to raise about HK$10.3 million

[Repurchase Cancellation]

HSBC Holdings (00005.HK) spent HK$231 million to repurchase 3.95 million shares on March 12

Standard Chartered Group (02888.HK) spent £237.997 million to buy back 3.531,900 shares on March 12

Yum China (09987.HK) spent HK$34.15 million to buy back 101,000 shares on March 12

Haier Smart Home (06690.HK) spent 16.9 million yuan to buy back 700,000 A shares on March 13

Swire Group A (00019.HK) spent HK$14.585 million to repurchase 221,500 shares on March 13